INTERCEPT PHARMACEUTICALS, INC. Quarterly Cost of Revenue in USD from Q1 2017 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary: Intercept Pharmaceuticals, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2017 to Q3 2023.
Intercept Pharmaceuticals, Inc. Cost of Revenue for the quarter ending September 30, 2023 was $197K, a 53.5% decline year-over-year.
Intercept Pharmaceuticals, Inc. Cost of Revenue for the twelve months ending September 30, 2023 was $632K, a 27.6% decline year-over-year.
Intercept Pharmaceuticals, Inc. annual Cost of Revenue for 2022 was $984K, a 18.3% decline from 2021.
Intercept Pharmaceuticals, Inc. annual Cost of Revenue for 2021 was $1.21M, a 48.8% decline from 2020.
Intercept Pharmaceuticals, Inc. annual Cost of Revenue for 2020 was $2.35M, a 44.1% decline from 2019.

Cost of Revenue, Trailing 12 Months (USD)

Cost of Revenue, Quarterly (USD)

Cost of Revenue, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2023	$632K	$197K	-$227K	-53.5%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-06
Q2 2023	$859K	$185K	-$124K	-40.1%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-02
Q1 2023	$983K	$222K	-$1K	-0.45%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-04-27
Q4 2022	$984K	$28K	+$111K		Oct 1, 2022	Dec 31, 2022	10-K	2023-03-02
Q3 2022	$873K	$424K	+$200K	+89.3%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-06
Q2 2022	$673K	$309K	+$55K	+21.7%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-02
Q1 2022	$618K	$223K	-$587K	-72.5%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-04-27
Q4 2021	$1.21M	-$83K	+$2.12M	+96.2%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-02
Q3 2021	-$914K	$224K	-$1.6M	-87.7%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-01
Q2 2021	$688K	$254K	-$1.62M	-86.5%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-03
Q1 2021	$2.31M	$810K	-$42K	-4.93%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-06
Q4 2020	$2.35M	-$2.2M	-$4.68M	-189%	Oct 1, 2020	Dec 31, 2020	10-K	2023-03-02
Q3 2020	$7.03M	$1.83M	+$1.34M	+275%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-03
Q2 2020	$5.69M	$1.88M	+$1.2M	+177%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-07-29
Q1 2020	$4.49M	$852K	+$278K	+48.4%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q4 2019	$4.21M	$2.47M	+$1.47M	+146%	Oct 1, 2019	Dec 31, 2019	10-K	2022-03-02
Q3 2019	$2.75M	$487K	-$32K	-6.17%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-09
Q2 2019	$2.78M	$677K	-$36K	-5.05%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-10
Q1 2019	$2.81M	$574K	+$294K	+105%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-11
Q4 2018	$2.52M	$1.01M	+$184K	+22.4%	Oct 1, 2018	Dec 31, 2018	10-K	2021-02-25
Q3 2018	$2.34M	$519K	+$347K	+202%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-05
Q2 2018	$1.99M	$713K	+$434K	+156%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-08
Q1 2018	$1.55M	$280K	+$183K	+189%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-08
Q4 2017	$1.37M	$823K			Oct 1, 2017	Dec 31, 2017	10-K	2020-02-25
Q3 2017		$172K			Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-01
Q2 2017		$279K			Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-07
Q1 2017		$97K			Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-10

* An asterisk sign (*) next to the value indicates that the value is likely invalid.